• / Free eNewsletters & Magazine
  • / My Account
Home>European Commission

European Commission

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. One Day Course: MiFID Compliance and Reporting (Central London, United Kingdom - December 8, 2017) - Research and Markets

    One Day Course: MiFID Compliance and Reporting (Central London, United Kingdom - December 8, 2017) - Research and Markets

  2. United Kingdom Mobile Infrastructure, Broadband, Operators Statistics and Analyses 2017 - Research and Markets

    United Kingdom Mobile Infrastructure, Broadband, Operators Statistics and Analyses 2017 - Research and Markets

  3. European Commission Grants Marketing Authorization for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Genotypes of Chronic Hepatitis C

    European Commission Grants Marketing Authorization for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Genotypes of Chronic Hepatitis C

  4. AstraZeneca: European Commission Approves Breast Cancer Treatment

    AstraZeneca: European Commission Approves Breast Cancer Treatment

  5. GRAIN HIGHLIGHTS: Top Stories of the Day

    GRAIN HIGHLIGHTS: Top Stories of the Day

  6. AGER to Acquire Aegon Ireland

    AGER to Acquire Aegon Ireland

  7. Omeros to Present at the 2017 Wedbush PacGrow Healthcare Conference

    Omeros to Present at the 2017 Wedbush PacGrow Healthcare Conference

  8. Moody’s Completes Acquisition of Bureau van Dijk

    Moody’s Completes Acquisition of Bureau van Dijk

  9. Top 3 Drivers Impacting Satellite-based EO Market Growth in Europe, by Technavio

    Top 3 Drivers Impacting Satellite-based EO Market Growth in Europe, by Technavio

  10. One Day MiFID Compliance and Reporting Course (Central London, United Kingdom - October 6, 2017) - Research and Markets

    One Day MiFID Compliance and Reporting Course (Central London, United Kingdom - October 6, 2017) - Research and Markets

12345

©2017 Morningstar Advisor. All right reserved.